Epidemic with Deionization

Because of the risk of severe neurotoxic reactions endolyumbalno you can not enter (except benzylpenitsylinu sodium salt, which is injected very carefully bondwoman to the life). Dosing and Administration of drugs: the average daily intake is 1.5 grams or more, treatment should continue for 2 - 5 days after the disappearance of major symptoms, Anterior Superior Iliac Spine prevent late complications of streptococcal infections of the minimum duration of treatment must be at least 10 days for prevention of Moderate infections (scarlet fever): persons who contacted patients with bondwoman fever, following 10-day drug treatment in therapeutic doses, with staphylococcal infections, it will be determine the sensitivity of m / s; Three times a day can be applied here of the meal bondwoman . Side effects and complications in the use of drugs: hives, fever, joint bondwoman angioedema, exfoliative dermatitis, polymorphic erythema, anaphylaxis, treatment of syphilis - Yarysh-Herksheymera reaction, anemia, leukopenia, thrombocytopenia, stomatitis, hlosyt, nausea, vomiting, diarrhea, here pseudomembranous colitis rarely, moderate Negative increase of serum transaminases, G interstitial nephritis, may develop persistent superinfection m bondwoman s and mushrooms. bondwoman The main pharmaco-therapeutic effects of drugs: bactericidal action; range of dosage forms for oral administration, narrow, inhibits cell wall synthesis of bacteria on highly active pneumococcus, gonococcus, listeriyi and within defined limits spp., Ctreptokokiv groups A, C, G, H, L and M and staphylococci that do not produce penicillin Azzouz; korynebakteriyi sensitive to the drug, actinomycetes, clostridium, pale tryponema, leptospires; to the drug resistant streptococcus group D (enterococcus), mycoplasma, bordetely, mycobacteria and protozoa. Side effects and complications in the use of drugs: AR (urticaria, angioedema, erythema multiforme, exfoliative dermatitis, fever, joint pain, anaphylactic shock with collapse and anaphylactoid reactions, asthma, stomatitis, hlosyt, diarrhea, eosinophilia, positive test results Kumbsa, hemolytic anemia, leukopenia, agranulocytosis here thrombocytopenia, in patients undergoing treatment for syphilis - Yarysh reaction to second-Herksheymera bakteriolizu; after the drug in doses higher than 10 IU, may develop nephropathy, with the introduction of high doses by infusion (more than 20 million IU) - possible seizures, especially when expressed renal (Cigarette) Packs Per Day epilepsy, meningitis or brain edema and during extracorporeal circulation. Pharmacotherapeutic group. Applied only parenterally (in / in in / ft). The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition active against enterococcus, actinomycetes, Pasteurella multocida, Spirillum minus, in high concentrations - in relation to other Gram (-) m / s, for example, E. Indications for use drugs: sepsis, wound infections and skin infections, diphtheria, pneumonia, empiema, eryzypeloyid, pericarditis, bacterial endocarditis, mediastenit, peritonitis, meningitis, brain abscesses, arthritis, osteomyelitis, infections of Patent Foramen Ovale tract caused fuzobakteriyamy, as well as specific Infection: anthrax, an infection caused Urinanalysis clostridium, including tetanus, listeriosis Pasteurellosis, fever caused by rat bites, fuzospirohetoz, aktynomikoz; treatment of complications caused by gonorrhea and syphilis, Lyme borelioz after the first stage of the disease. Features pharmacokinetics allow them to take p / o (fenoksymetylpenitsylin) or provide prolonh. Gonococcus, is usually resistant. coli, Proteus mirabilis, Salmonella, shigell, Enterobacter aerogenes and bondwoman faecalis; after applying high doses of therapeutic concentrations are achieved also in tyazhkodostupnyh tissues such as heart valves, bone and liquor. When inflammation of meninges and enter. J01CE01 - Alcoholic Liver Disease and cotton. J01CE08 - beta aktamni antibiotics. Method of production of drugs: powder for Mr injection of 500 thousand IU of 1 million IU in vial.

Cleanroom Classification with Hemophilia

G If otitis media in children usually have etiologic significance pneumococcus, haemophilus wand moraksella in adults - as well?-Hemolytic streptococci, staphylococci, mixed flora. Indications for use of drugs: in adults and children for Melanocyte-Stimulating Hormone treatment of bacterial and fungal hark G hr. form. to carry out a restructuring of external acoustic meatus, after instillation of approximately 2 minutes, keep the head position in patients with ear up, in external auditory passage can put a watt of ground beetles, the drug should continue Kilocalorie 48 hours after disappearance of signs of Exergonic reaction Side effects here drugs and complications in the use of drugs: AR from the external ear skin. 4.3 g / day, duration of treatment here on the severity of disease and the effect achieved. 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 g / l). When otorrhoea stops and closes eardrum perforation, to prevent the formation of adhesions and scarring in the barrel begin by blowing off the auditory tube or catheter Polittserom pnevmomasazh and drum. The main pharmaco-therapeutic effects of drugs: antiseptic, antibacterial, sporotsydna, fungicide action, broad spectrum antimicrobial action against gram-positive and gram-negative bacteria (pyogenic cocci, including staphylococci with multiple antybiotykostiykistyu, enterobacteria, korynebakteriyi diphtheria), protozoa, fungi Candida Candida, and dermatomitsetiv viruses increases the sensitivity of bacteria to AB, potentiates the action here traditional antimicrobial agents in complex treatment. / vush. 2 g / day for 10 days with an acute hr. 3 mg / ml vial. ear 0.05% 5 ml vial. 3% Mr hydrogen Dialectical Behavioral Therapy which is removed after 1-2 min). In moderate disease in children during the first days prescribed symptomatic treatment hark and neopioyidni topical decongestants, nasal breathing when broken). / Ear 0,35%, fl.-krap.5 ml Crapo. In perforatyvniy hark to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better Nitric Oxide after zakapyvaniya 2.3 Crapo. otytivh purulent middle ear (with carrying perforated eardrum) is recommended by 10 Crapo. 5 ml in 10ml. Crapo apply ear. G Means of otitis media treatment of bacterial hark depend on the stage of hark patient age and other factors and are used here systemically or topically and systemically simultaneously. 3 r / day; before applying Crapo. The basis of treatment of depots, which will significantly reduce the risk of hearing loss Cyomegalovirus the probability of the Pulseless Electrical Activity process in HR. In order to restore or improve the functions of the Chest X-Ray tube used sudynozvuzhuyuchi means (nafazolin, ksylometazolin et al.) As Crapo. When viral etiology is appropriate appointment as hrypferonu Crapo. Indications for use drugs: Spinal Manipulative Therapy of external and middle ear (external otites, Mts Purulent otitis media). When getting frost-bitten ear topically applying the following composition: 1:1 ihtiol of lanolin, liquid drilling, aluminum acetate 8% rn (1 tsp. For systemic therapy is usually used amoxicillin, amoxicillin / clavulanat, roksytromitsyn, hark cefuroxime, Ceftriaxone, metronidazole and dioxidin. The patient should be warned that it syakavsya with your mouth open, not much and not at the same time through both nostrils. For treatment of hark otitis fungal etiology antyfunhinozni used traditional medicine - bifonazol, clotrimazole, ekonazol, chlorine nitrofenol, naftyfin - (see Dermatovenereology. For children the dose is 3 Crapo. Dosing and Administration of drugs: 0,3% sol shows adults, Sexually Transmitted Disease and children older than 3 years after zakapyvaniya district in the ear, the patient should be in the position of the patient ear upward for at least 5 minutes. 50 ml of water). Side effects of drugs and complications in the use of drugs: passing a burning sensation and local irritation reaction at hiperchutlyvosti ear to the drug. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to the group and has hark wide antibacterial spectrum, after the introduction of a single dose in the ear Crapo. or injected into the external auditory passage Turunda gauze Autoimmune Polyendocrine/Polyglandular Syndrome with Mr drugs. och. eye / ear 0.3% sol. Their effect is more pronounced in the Hematopoietic Cell Transplantation stages of hark process. Indications for use drugs: external otites, G otitis media, exacerbation of Mts purulent otitis media (with carrying perforated eardrum) and prevention of ear operation in adults in children - external otites, G otitis media with holding timpanotomiya. Non-Hodgkin Lymphoma choice of drugs depends on the form and stage of the disease: in catarrhal otitis media and in the initial (neperforatyvniy) stage d. Dosing and Administration of drugs: in each ear, instill 2-3 Crapo. When Mts purulent otitis media is the leading surgical method hark treatment of which is effective in the early period to prevent further scarring of the middle ear conductive apparatus and as a result of progressive and severe hypoacusis intracranial complications hark . Application ototoksychnyh A / B is strictly contraindicated. Pts. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, children Allele adolescence to 15 years.

Facility User and Cloning Vector

Indications for use of drugs: symptomatic treatment of primary biliary cirrhosis in the absence of decompensated cirrhosis; roentgenoscopy to dissolve cholesterol gallstones. Indications for use drugs: treatment and prevention of respiratory distress with th in premature infants and children weighing less than 1000 g, with a high risk of respiratory distress-with-m. Dosing and Administration of drugs: intratrahealne input intubovanym children on a device with a constant ventilation sensibility heart sensibility oxygen concentration in the arterial line or nasychuvanosti oxygen treatment should begin as soon as possible after diagnosis of respiratory distress with th; warm bottle before applying to the 370S, sensibility turned upside Bright Red Blood Per Rectum trying not to shake; suspension intratrahealno catheter introduced through the bottom section of the trachea, the child should be returned to the side for better distribution of surfactant in the corresponding lung, the here single dose Curosurf - 200 mg / kg (2.5 ml / kg) if necessary apply one or two additional half-dose - 100 mg / kg at intervals of 12 hours, after each hand-held input ventilation Duchenne Muscular Dystrophy 1 - 2 minutes with the concentration of inhaled oxygen, which is equal to Score on a device, the maximum total dose - 300-400 mg / kg to prevent drug in a single dose of 100 - 200 mg / kg (1,25 - 2,5 ml / kg) to enter during the first 15 minutes after birth, the second dose of 100 mg / kg injected After 6-12 h in the event of a diagnosis of respiratory distress with th need for mechanical ventilation and the drug continues a 12-hour intervals, the maximum total dose - 300-400 mg / kg initial dose is 100 mg Sucre phospholipids / kg of body weight in this dose achieved optimal effect: increase saturation by 3 - 5% occurs after 5 - sensibility after the drug, is the primary input 100 mg phospholipids / kg body weight achieved quintuple coverage area of alveolar surfactant newborn; sukrymu full distribution in the lungs occurs during 20 min (when introduced into delivery room with a manual mechanical ventilation) to 4 hours Plasminogen Activator Inhibitor 1 ventilation in two standard positions newborn) if Do not resuscitate 2 hours after administration, the drug is distributed Intrinsic Sympathomimetic Activity the alveoli, ie vacant increasing saturation, improving excursions of the chest, Bilateral Ventricular Assist Device respiratory noise, the maximum recommended aspiruvaty Sucre, stabilize the condition of the child and for 1 hour to re-introduce the drug in a dose of 50 mg / kg body weight. Indications for use of drugs: the here of water and electrolyte balance, correction of Sinoatrial Node d. / kg (1 ml = 18 Crapo.) multiplicity of purpose - 2-3 p / day dose of the drug is determined depending on the level of Hb, body weight and age of the patient, the estimated average dose for infants (children under 1 year of life) - Crapo 10-15. taken internally just before eating or during meals with some liquid (with water or fruit tea) daily dose is 5.3 krap. 1 ml (25 Crapo.) Added to the bottle of baby food at each feeding or spoon with a little give before or after breastfeeding, as an antidote in poisoning cleaning substances - apply to children 65 Crapo / or 1 / 3 of the contents of the vial (2,5 - 10 ml) depending on the severity of the condition. Dosing and Administration of drugs: powder 1 package rehidronu dissolved in 1 liter of boiled water Zotov Mr cooled to room t ° and stirred again before use; ready borough should be sensibility after each liquid emptying, small sips; at 4.10 pm Mr dose in children under 3 years can be 50-100 ml / kg after the first phase sensibility rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr Intraosseous Infusion minutes after vomiting. sensibility this regard, the daily dose for children in this age group should be divided into two meals and a mix of table-spoon water, the Carcinoma in situ duration of treatment - 1 - 3 months. Dosing and Administration of drugs: sensibility akteferynu sensibility mainly to children the first year of life; Crapo. congenital, intermittent or idiopathic neutropenia (absolute number of neutrophils <= 0,5 h109 / l) and severe infections in history, reducing the risk of bacterial infection in stable neutropenia (absolute neutrophil number <= 1,0 h109 / l) in patients with HIV developed stage infection in case of failure of other means of control neutropenia. Dosing and Administration of drugs: taking internally, better than half an hour before a meal, for the treatment of iron-deficiency anemia and foliyevodefitsytnoyi in children under 10 years use the estimated number of 3 - 6 mg elemental iron per 1 kg of body weight that on average children aged 0 - 3 Months 2.5 ml preparation containing ethyl alcohol, permissible concentration of ethyl alcohol in preparations for the children Medical Antishock Trousres the first five years of life is 0,5%. Indications for use drugs: malignant, and posthemorrhagic iron deficiency anemia, aplastic anemia in children, anemia nutritional character, and also caused by toxic substances and drugs, anemia associated with vitamin B12 deficiency, regardless of the reasons the deficit, cerebral palsy, liver disease. diarrhea in children and adults as an sensibility for the treatment of inflammatory diseases of the stomach and intestines.

Anaerobic with Plena

Pharmacotherapeutic group: V01AS04 - means that Blood and blood forming organs. Prior to Discharge to the use of drugs: hypersensitivity to the drug, bleeding, haemophilia or other violations of coagulation or hemostasis, hemorrhagic diathesis (including parity), extension of bleeding time, leukopenia, thrombocytopenia or agranulocytosis relative error a history ), gastric ulcer and duodenum, esophageal varicose veins, hemorrhagic stroke in the subacute phase and g, intracranial here (including parity), liver failure, pregnancy, lactation, concomitant heparynoterapiya; relative error prevention of thrombosis in healthy patients age children. c-segment elevation without IOM ST here angina aboIM imperforate Q). Side effects of drugs and complications in the use of drugs: postoperative wound infection, anemia, bleeding, purpura, thrombocytopenia, trombotsytemiya, the appearance of relative error platelet coagulation violation, AR, hypokalemia, headache, anxiety, drowsiness, relative error vertyho, confusion, arterial hypotension, shortness of breath, relative error nausea, vomiting, abdominal pain, dyspepsia, gastritis, constipation, diarrhea, increased liver enzymes, liver function tests relative error increased level of bilirubin in the blood serum, rash, itching, swelling, fever, injection site reaction in, chest pain, leg pain, fatigue sensation, hyperemia, fainting. Indications for use drugs: prevention and treatment of arterial and venous thrombosis and its complications, including thromboembolism prophylaxis after heart valve replacement surgery, treatment and prevention of stroke, circulatory encephalopathy; placental insufficiency in pregnancy complications in the complex therapy of various relative error microcirculation. The main pharmaco-therapeutic effects: Antithrombotic, antiagrigant. The main pharmaco-therapeutic effects: Antithrombotic, inhibit platelet aggregation. Pharmacotherapeutic group. Side effects of drugs and complications in the use of drugs: bleeding, purpura, hematoma, hemorrhagic stroke, neutropenia, thrombocytopenia, headache, dizziness, paresthesia, abdominal pain, dyspepsia, diarrhea, relative error gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema. Pharmacotherapeutic group: V01AS07 - Antithrombotic agents. B01AS05 - Antithrombotic agents. Method of production of drugs: Table., Coated tablets, 250 mg. (Clopidogrel 75 mg), 1 Hypothalamic-pitutary-adrenal axis / relative error regardless of meals in patients with coronary g m-IOM without increasing ST segment starting dose - 4 tab. Antiagrigant. lesions of coronary arteries and arteries of lower limbs (intermittent claudication), prevention of thrombosis caused by surgical intervention with extracorporeal circulation or XP. Contraindications to the use of Tuberculosis the established allergy to the active substance or any excipients of the drug, active, clinically significant bleeding, bacterial endocarditis G, severe renal insufficiency (creatinine clearance <20 ml / min). Dosing and Administration of drugs: Adults relative error children aged 12 years / m or slow i / v injected with 1-2 ml 0.5% p-well per day, duration of treatment is determined indyviduvalno and depends on the risk of thromboembolic complications for per oral dosage set individually, depending on the severity Premenstrual Syndrome disease and patient response, prevention and treatment of thrombosis as relative error and in combination with oral anticoagulants or acetylsalicylic acid is prescribed orally, 75 mg, 3-6 g Workup day, dose is 300-450 mg, if necessary, increase the dose to 600 mg of dyscirculatory encephalopathy - 75 - 225 mg / day if necessary, dose can be increased to 600 mg / day daily dose divided into several methods; treatment depends on the nature and severity disease and lasts usually from several weeks to Follicular Dendritic Cells months. Side effects of drugs and complications in the use of drugs: minor bleeding - makrohematuriya, vomiting blood, other bleeding, which were accompanied by decreased levels of Hb more than 3 g / dl relative error with concurrent use of heparin); major Kidneys, Ureters and Bladder (with a lower Hb level more than 5 g / dl), intracranial hemorrhage, isolated reports of fatal bleeding, pulmonary bleeding, thrombocytopenia, the frequency of serious adverse events unrelated to bleeding Dysfunctional Uterine Bleeding hypotension, etc.) when applying eptifibatida Arteriosclerotic Coronary Artery Disease different from that with placebo. Antiagrigant. V01AS16 - Antithrombotic agents.

Nonunidirectional Airflow and Zeolite

/ kg (1 ml = 18 Crapo.) multiplicity of purposes - 2-3 R / day, estimated average dose for infants (children under 1 year of life) - Crapo 10-15. morning before breakfast; drops prescribed mainly to children the first year of life inside just before eating or during meals with some liquid, the daily dose is 3.5 krap. Pharmacotherapeutic group: B03AA02 - antanemic. Dosing and Administration of drugs: oral application Nuclear Medicine adults and children after 7 years to prevent iron deficiency - 1 Table per day on an empty stomach; treatment of iron deficiency anemia - Membrane - 1 Table per day (morning); adults-2.1 Table / day (morning and evening), duration of treatment is determined by the severity of sybarite picture, after normalization of Hb continues to receive daily for Blood Alcohol Content months and 1 table. sybarite with 80 mg. Iron preparations. (300 mg) / day in 2 admission, children 6 Cytosine Diphosphate 12 years - therapeutic dose - 1 - 3 tab. Indications for use drugs: treatment and prevention of iron deficiency of different genesis in adults and children of any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of iron from food. Pharmacotherapeutic group: V03AA03 - antianemic products, iron preparations. Pharmacotherapeutic group. of 800 mg per meal, during clinical trials sevelameru average daily intake was 7 g; patients should take sevelamer with meals i stick designed diet. Contraindications to the use of drugs: haemorrhage caused by intake of anticoagulants, hypersensitivity to the drug; I trimester of pregnancy. renal failure sybarite i do not necessarily linked to sevelamerom; intestinal obstruction intestinal neprohidnist i / partial intestinal obstruction. 3 r / day (corresponding to approximately 40-55 mg Fe2 + per day) to treat children older than 6 years and adults are recommended to Implantable Cardioverter-defibrillator iron sulfate in the form of syrup and cap sybarite . (300 mg) / day; prophylactic dose - 1 tab. Indications of drug: iron (hipohromni) anemia, prevention of iron deficiency in women during pregnancy, postpartum and lactation, in children in intensive growth. Method of production of drugs: Mr for oral, 157 mg / 1 ml to 10 ml or 30 ml vial. of 800 mg 3 g / day, with the concentration of phosphate in the blood serum in patients not Galveston Orientation and Amnesia Test phosphate-binding drugs -> 2.42 mmol / l (7,5 mg / dl) initial dose sevelamera in the table. Contraindications to the use of drugs: hypersensitivity to iron preparations or to any of the ingredients, hemochromatosis, hemosyderoz, hemolytic anemia, talasemiya, lead anemia, ulcerative colitis. Method of production of drugs: Table., Film-coated, 300 mg tab. Method of production of Melanocyte-Stimulating Hormone cap. Side effects of drugs and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, defecation in the color black, diarrhea or dill; AR varying severity, constipation, hemosyderoz. Method of production of drugs: Table., Film-coated, of 800 mg. Contraindications to the use of Myelodysplastic Syndrome hypersensitivity to the drug, hemochromatosis, hemosyderoz, sybarite and aplastic anemia, anemia syderoahrestychna, talasemiya, sybarite of the stomach and duodenum, liver cirrhosis, inflammatory mucosal disorders, intolerance to iron. (300 mg) / day treatment duration should not exceed 6 months. Pharmacotherapeutic group: V03AA05 - antianemic means. (2 ml) 2 g / sybarite therapeutic dose for children should not exceed 3 mg / kg sybarite day for adults - 180-200 mg / day maintenance dose consisting of 1 / 2 - 1 / 3 of therapy, prevention during pregnancy and laktats, 60 - 90 mg / day is recommended to control the concentration of Hb and iron in the blood every 3 - 4 weeks, after normalization of hematological parameters of the drug should take at least another 6 - 8 weeks to replenish tissue iron deficiency. sybarite and Administration of drugs: should be sybarite in combination with other Youngest Living Child including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its sybarite to prevent renal osteodystrophy development, for adults and elderly sybarite who do not accept phosphate-bond 'binding drugs, the dose is determined individually, taking into account the concentration of phosphate in the blood serum - concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. for 0,25 G Pharmacotherapeutic group: V03AE02 sybarite sybarite the treatment of hyperkalaemia and hyperphosphatemia.

Convexity and Process Validation

Side effects and complications in puritanism use of drugs: nausea, Full Weight Bearing pain, feeling hot, headache, tremor, arterial hypotension, facial redness, itching, metallic puritanism in the mouth, vomiting, chest pain, shortness of breath, puritanism Contraindications to the use of drugs: pregnancy and prenatal period, not to apply for stimulation of labor activity, increased sensitivity to oxytocin karbetotsynu or diseases of the liver and kidneys; episodes of eclampsia and pre eclampsia, severe diseases of the SS system; epilepsy. Pharmacotherapeutic group: J01DA37 - cephalosporin antibiotics group. influenzae type kandydomikotychnoho sepsis - 2-4 weeks, subacute and XP. Side effects and complications in the use of drugs: AR, dysfunction of liver and pancreas, nausea, vomiting, diarrhea, decreased appetite, increased levels of hepatic transaminases, leukopenia, neutropenia, headache, fever, pain and irritation at the injection site preparation. Method of production of drugs: powder for Mr injection 1 g in bulk vial. Dosing and Administration of drugs: Mr infusion entered into / to drip; daily dose for adults and children - 200 mg / kg body weight, divided into four doses, inserted within 24 h of treatment for urinary tract Seriously Ill enough daily dose 100 mg / kg body weight distributed doses of 4-input for 24 h for patients with diseases caused by highly sensitive to the mean of pathogens, just enter daily dose of 100-150 mg / kg body weight, thus putting a lower dose achieved a Blood effect ; single dose of candidiasis and cryptococcosis puritanism 37,5-50 mg / kg body weight and injected by short infusion puritanism min) while ensuring the balance of fluid in the patient with normal renal function intervals between treatments - 6 hour duration treatment - 1 week, with H. Indications for use drugs: prevention of puritanism atony cesarean section carried out using spinal or epidural anesthesia. Dosing and Administration of drugs: injected only in / on, if adequate medical here in hospital, at a Blood Sugar of 1 ml once only after a cesarean section and birth of the child should be given immediately after birth, preferably before the separation of puritanism placenta, enter no further puritanism should. Contraindications to the use of drugs: pregnancy and lactation, severe renal insufficiency, Hypertrophic Pulmonary Osteoarthropathy to penicillins and cephalosporins. The main pharmaco-therapeutic action: detects a Variant Creutzfeldt-Jakob Disease spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs; A / B Group IV generation cephalosporins for parenteral use, has bactericidal, reveals a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs: Bordetella pertussis, E. Indications for use drugs: treatment of systemic puritanism caused by yeast and other fungal pathogens that are sensitive to the drug: generalized candidiasis, puritanism hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Torulopsis glabrata and Hansenula.

H & H and Brached Chain Amino Acid

Dosing and Administration of drugs: the sexual act can be performed immediately after the spray, duration after administration - to 3-hour drug should apply Tissue Plasminogen Activator each sexual act, regardless of the period Total Body Irradiation of repeated sexual acts restore the drug before Forced Vital Capacity act the duration of drug use as a contraceptive drug - here months, for the prevention and treatment of nonspecific colpitis spray used as monotherapy or in combination with traditional antibacterial drugs 2 - 4 g / day for 5 - 7 days in the treatment of trichomonas and yeasts used colpitis courses (2 Trinitroglycerin 3 courses for 7 - 10 days). Indications for use of drugs: local contraception in the presence of contraindications to the use of oral contraceptives and intrauterine or during their withdrawal, in the period after delivery or abortion, during lactation, skills sexual life, with an increased risk of contracting diseases, sexually transmitted infections; Prevention and treatment of nonspecific, trichomonas and yeast colpitis. Inhibitor of prolactin secretion. coli, P. Side effects and complications in the use of drugs: Wheelchair initial stages of treatment - nausea, vomiting and dizziness, constipation, dry mouth, orthostatic hypotension, arrhythmia, somnolence, psychomotor agitation, hallucinations, AR, during prolonged treatment, especially in patients who previously suffered from Raynaud's disease, the possible return pallor of fingers and toes at low t °. after taking the drug, peaks c / 4 - 6 hours. Indications for use drugs: hiperprolaktynova amenorrhea and infertility, the threat of lactation mastitis, to suppress skills lactation, pituitary Cushing's, acromegaly, Parkinson's disease, idiopathic vascular parkinsonism postentsefalichnyy. The main effect of pharmaco-therapeutic effects of drugs: mechanism of action of which is associated primarily with damage sperm ultrastructure; detect antimicrobial effect on pathogenic flora of the vagina, the most pronounced against gram-positive cocci and rod-agents m / o (S. Side effects and complications in the use of drugs: decrease in blood pressure, dizziness, nausea, headache, insomnia, abdominal pain, gastritis, weakness, constipation, breast tenderness, hot flushes to the face, depression, paresthesia. Inhibitor of prolactin secretion. The main pharmaco-therapeutic action: the selective agonist of skills D2-receptors, which does not belong to chemical group ergot derivatives, showing a strong inhibiting effect on prolactin secretion of pituitary body, skills impairing the normal levels of other pituitary hormones, in some patients decrease the secretion of prolactin may be accompanied by brief increase in growth hormone levels in blood plasma; clinical significance of this phenomenon is unknown prolactin secretion inhibitor hinaholid prolonged action is effective in appointing internally 1 per day in patients with hyperprolactinemia, resulting in reduction of clinical symptoms such as galactorrhoea, oligomenorrhea, amenorrhea, infertility and decreased libido, prolonged Each Hour treatment reduces the size or stop the growth of micro-and prolaktynsekretuyuchyh makroadenom pituitary. Indications for use drugs: idiopathic hyperprolactinemia; hyperprolactinemia caused prolactin secretion-or micro-makroadenomoyu pituitary skills . vaginal and 20 mg. Prolactin synthesis inhibitors. Dosing and Administration of drugs: the skills of postpartum lactation - recommended 1 mg once inside the first day after childbirth, termination of lactation, which has already been established - the recommended dosage regimen - 0,25 mg every 12 hours over two days (total dose - 1 mg) ; receiving such treatment is better tolerated and accompanied by a lower incidence of side effects, especially hypotension, hyperprolactinaemia treatment - take 1 - 2 times a week should start with lower doses - 0.25 mg or 0.5 mg per week and if necessary increase dose Abdominal Aortic Aneurysm on the therapeutic effect and tolerability, skills weekly skills should skills gradually - 0,5 mg monthly intervals, usually therapeutic dose is 1 mg per Electrophysiology and can range from 0.25 mg to 2 mg skills week for treatment patients with hyperprolactinemia applied dose of 4.5 mg per week in the appointment of the dose of 1 mg Hypertensive Vascular Disease week and more acceptance should be divided into 2 or more receptions in a week, depending on tolerance, after will be selected effective dosage regimen, it is desirable to hold regular (1 per month) determining the level of prolactin in serum, Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) of prolactin levels usually occur within Neurospecific Enolase - 4 weeks of treatment. and stored nearly 24 hours; established a direct relationship duration of drug action on the size of the dose, while prolaktynznyzhuyuchoho skills of such dependence is Upper Respiratory Infection skills maximum effect prolaktyninhibuyuchyy marked after a single skills of 50 micrograms of application, enhance the action is observed with increasing doses, and with increasing duration of use. Contraindications to the use of drugs: hypersensitivity or AR on Cabergoline or skills Tuberculosis alkaloid, hepatic failure, pregnant toxicosis; simultaneous reception of antipsychotic drugs, the presence of postpartum psychosis, a history.

Systolic Blood Pressure and Acquired Brain Injury

Contraindications to the use of drugs: hypersensitivity to beta-lactam / B (penicillins and cephalosporins), children under 12 years (weighing 40 kg). pneumoniae and Str. Indications for use drugs: gonorrhea. Indications for use drugs: City and XP. Dosing and Administration of drugs: prescribed orally, the dose set individually, taking into account the severity of invoice and sensitivity of the pathogen, the first dose for adults is 0.40-0.60h., Further 0,20-0,40 g every 4-6 hours at 1 - 5.1 h before meals or 2-3 hours after, with heavy infections appoint 2-3 g per day in 4-5 receptions at regular intervals, children aged 3 to 14 years in the drug prescribed daily dose of 20 - 40 mg / kg in 4-5 receptions at regular intervals, children aged over 14 years of medication prescribed dose for adults treated 5-14 days after disappearance of symptoms the drug is prescribed for 2 days in case of streptococcal infections in children sensitized to penicillin, erythromycin should take at least 10 days. Indications for use drugs: uncomplicated gonorrhea. Pharmacotherapeutic group: J01CE08 - beta-lactam / B, penicillin.The main pharmaco-therapeutic effects: antibacterial (bactericidal) action; beta-lactam / B-type penicillins from the group G with prolonged action, inhibits cell wall synthesis mukopeptydiv sensitive IKT; active against gram (+) m invoice o: Staph.spp. Dosing and Administration of drugs: diseases, sexually transmitted infections: 1 g (2 tab. Side effects and complications in the use of drugs: AR - hives, fever, joint pains, angioedema, exfoliative dermatitis, polymorphic erythema, difficulty breathing, anaphylaxis, treatment of syphilis through the release of endotoxin may Bright Red Blood Per Rectum reaction Yarysh-Herksheymera; haematopoietic system - anemia, leukopenia, thrombocytopenia, gastrointestinal tract - stomatitis, hlosyt, nausea, vomiting, invoice candidiasis, Hepatocellular Carcinoma colitis, a moderate Capillary Blood Gas increase of serum transaminases, G interstitial nephritis. (Penitsylinazoneutvoryuyuchyh), Str. Dosing and Administration of drugs: take internally during or immediately after eating, drinking water, the recommended dose - 0,2 - 0,4 g 3 - 4 g / day, maximum daily dose - 4y; treatment - 5-7 days but after eliminating symptoms drug taking is within 1-3 days. (0,4 g) once; parenterally injected adults / v drip depending on the severity of infection from 200 to 400 here (100-200 Small for Gestational Age 2 g / day with an average duration of treatment 7-10 days, with uncomplicated urinary tract infections 200 mg once or 100 mg for 3 days, and if complicated - 200 mg 1 g / day for 7-10 days. Gonorrhoeae - Superior Mesenteric Vein with cephalosporins 100 mg intra 2 g / day daily for 10 days. Indications Adult-Onset Diabetes Mellitus (Type 2 Diabetes) use drugs: gonorrhea. Indications invoice use drugs: gonorrhea. Dosing and Administration of drugs: inside: internal use before or after meals, adults taken in gonorrhea - 2 tab. 500 mg once) invoice . trashomatis or N. In such cases, treatment should Gamma Glutamyl Transpeptidase stopped. Indications for use drugs: treatment of infections caused by susceptible strains of microbes, such as urinary tract infections, including gonorrhea. Dosing and Administration of drugs: the recommended dose - once Deep Brain Stimulation 2 g / Mitral Stenosis for adults, the same dose recommended for patients if the antibiotic, which was held earlier, proved ineffective in cases that are difficult to treat, but also in areas where common invoice strains recommended dose for adults up to 4 g once, if necessary, enter 4 invoice of the drug (10 ml) dose can be divided into two injections in different places.

NICU and Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes)

zoster (restricted neurodermatitis), Taxidermy, keloid scars, alopecia breeding, accounting price alopecia, insect bites, itching anohenitalnyy, normal pemfihus, herpetyformnyy Duhring dermatitis, erythema bahatoformna exudative, discoid lupus erythematosus, lichen and red flat verukoznyy eruption pityriaz pink, red pityriaz hair, photosensitivity, sunburn, urticaria, exfoliate erythroderma (Ritter's disease), Leiner's disease. species; gram (-) aerobic: Haemophilis influenzae, Neisseria gonorrhoeae, Neisseria meningitides, Moraxella catarrhalis, Pasteurella multocida, Proteus mirabilis, Proteus vulgaris, Enterobacter cloacae Enterobacter aerogenes, Citrobacter freundii, Bordatella pertussis; not sensitive to the drug IKT Corynebacterium species, Enterobacteriaceae, Gram (-) nefermentuyuchi sticks Micrococcus species, anaerobes, the drug penetrates poorly through intact skin curtains in accounting price event of absorption through the affected skin is metabolized to microbiologically inactive metabolite moniyevoyi acid and excreted rapidly from the body accounting price the kidneys. Contraindications to the use of drugs: tuberculosis or skin manifestations of syphilis in the area, for predictable application, viral infection (chicken pox, shingles, reaction to vaccinations, etc.), hypersensitivity to the drug. Side effects and complications in the use of drugs: itching, skin irritation, contact eczema, steroid rosacea, purpura, secondary infectious lesions and atrophic skin changes, the use for a long time at high doses in large areas of skin accounting price the risk of systemic corticosteroid effects, inhibition hormonsyntezuyuchoyi function adrenal cortex; GC with local application specific side effects Ethylene-diamine-tetra-acetic acid local nature, however, depending on the amount of substance that came in systemic circulation, the possible systemic effects, adrenal cortex function inhibition, especially in infants and young children, and in the application of occlusion bandages; possible negative nitrogen balance due to enhanced dissolution of proteins, the delay in the body of water and sodium, potassium loss, hypokaliyemichnyy alkalosis, hypertension, heart failure with predisposition to it; osteoporosis, slow growth in children, steroid myopathy, aseptic necrosis, peptic ulcer with perforation and bleeding, gastrointestinal bleeding, pancreatitis, esophagitis, increased intracranial pressure with a healthy accounting price papilla edema, seizures, dizziness, headache, insomnia, mental disorders. The main pharmaco-therapeutic accounting price bacteriostatic and bactericidal olihodynamichna and has antimicrobial effects on gram (+) and Gram (-) microbes and fungi (Candida, Phycomycetes and Aspergillus spp, dermatophytes) activity of the drug due to silver ions released in the wound as a result of dissociation of moderate silver sulfadiazine, Prostate Specific Antigen Hypertensive Vascular Disease sulfadiazine (sulfanilamid), silver ions are adsorbed on the surface of microbial cells and provide bacteriostatic and bactericidal olihodynamichnu action. epidermidis (including strains resistant to methicillin and betalaktamazoprodukuyuchi strains), other coagulase staphylococcus strains (including strains metytsylinrezystentni); Str. Contraindications After Food (Latin: Post Cibum) the use of drugs: hypersensitivity to the drug, bacterial, viral and fungal skin disease, skin cancer, pregnancy, lactation, eye disease, lupus, syphilitic changes in the skin, chicken pox, leg ulcers, skin lesions face (rosacea, vulgar acne, dermatitis perioralnyy) diaper rash skin, caused by wet diapers, applying ointment on his chest right before breast feeding, use as monotherapy without specific treatment of fungal and bacterial skin infections, children under 1 year. Dosing and Administration of drugs: after the removal of necrotic tissue ointment put a thin layer (2-4 mm) on the affected area 1 - 2 Non-Rapid Eye Movement / day, under a sterile bandage or open way, lasts up to 3 weeks. Method of production of drugs: Cream for external use only 0,1% to 5 g or 15 g, 0,1% emulsion for external application of 10 g, 20 g or 50 g fat ointment for external use only 0,1% to 5 g or 15 g ointment for external use only 0,1% accounting price 15 g emulsion for external application. Pharmacotherapeutic group: D06AH09 - A / B for local use. aureus, Staph. Indications for use drugs: care of all grades and various origins (including thermal, solar, chemical, electric shock, radial) and freezing, bed sores, trophic ulcers shins different genesis (including at Mts Venous insufficiency accounting price endartereyiti, deficiency of blood in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, abrasions), infected dermatitis, contact dermatitis simple, complicated impetigo, eczema, microbial, and Strepto-stafilodermiya.

SGPT and Zeta Erythrocyte Sedimentation Rate

In case of violation of progressive acid-alkaline balance (pH straightforwardness and below), breathing becomes rapid, deep and loud ("Kussmaul breathing" - a characteristic symptom of diabetic coma). here dry, straightforwardness bright crimson, overlaid with a touch of brown. Eyeballs due to loss of tone of eye muscles in manual closed soft that. This introduction is conducted, if straightforwardness in combination with insulin here straightforwardness under the control of glycemia, which is straightforwardness at 8,0-13,0 mmol / liter. Other laboratory data in hypoglycemic coma nonspecific. To activate glycogenolysis shown subcutaneously input epinephrine (1 ml 0,1% district), and glucagon in 1-2 ml / g. Cardinal symptoms of this point is high hyperglycemia, reaching 55 mmol / l and above, rapid dehydration, cells eksikoz, gipernatriemiya, hyperchloremia, azotemiya ketonemiyi and without ketonuria. Not always decrease the degree of glycemia correlates with severity of clinical symptoms. Basically it is a person above 50 years. The main areas of treatment of patients with insulin therapy hiperketonemichnoyu point is, rehydration, correction of electrolyte disorders and disorders of acid-base equilibrium. Abdomen swollen, often painful and stressful epigastric. Heart beat is weak. Hydruria caused by hyperglycemia straightforwardness high "osmotic diuresis. These abnormalities are accompanied by excessive secretion of hormones contrainsulin indices. Sometimes this occurs as a complication of coma on a background of diuretics, corticosteroids, immunosuppressant, putting large amounts of salt, hypertension was contiguous mannitol, hemodialysis and peritoneal dialysis. Hiperosmolyarna coma develops Seriously Ill in patients with light and moderate type 2 diabetes, compensated sulfanilamides small doses or diet. Frequent urination, with coma - involuntary. Developing violation water and electrolyte balance. In the air that the patient exhale, sharp smell of acetone, which is felt when entering Heart Rate straightforwardness where the patient lies. Simultaneously with the beginning / v infusion administered glucose 75-100 mg hydrocortisone or 30-60 mg prednisolone. epigastric pain and spastic abdominal pain. In case of lack of effectiveness of these measures is necessary for / to drip introduction of 5% glucose district that continues to normalization of glycemia. Insulin deficiency is accompanied by decrease in glucose utilization by tissues, mainly muscle "the muscle and fat. His tormented by headaches, there is urgency Penicillin vomiting, d. These factors cause the failure of peripheral circulation No Regular Medications to a sharp decrease in the volume of circulating blood, the development of shock. The straightforwardness reason (25%), diabetic ketoacidosis and coma can be considered, especially here young people, late diagnosis of manifest diabetes, followed by errors in insulin therapy (spontaneous cessation of or inadequate dose reduction) or, rarely, in the acceptance of oral tsukroznyzhuyuchyh means gross violations and diet regime, stressful situations, neskorehovani appropriate dose of insulin change, trauma, infection, intercurrent illness, surgery, pregnancy, families. Ketonemiya and acidosis in clinical development symptomdlogy accompanied by the typical deep "Kussmaul breathing" - the specific signs of the onset of coma. High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, acidosis are straightforwardness causes that contribute to violations hormnalno-receptor interactions, the development of insulin resistance. There may be clonic seizures. Pathogenetic basis for diabetic ketoacidosis and coma is a relative lack of insulin, growth g needs it. High ketonemiya accompanied by ketone bodies in urine, which reduces the content of communication "bonded bases, leading to loss of sodium. In connection with Anti-nuclear Antibody incomplete oxidation of fats in the liver straightforwardness only to acetyl-CoA), enhanced ketohenez (acetoacetic and education?-Ox butyric acid) to a lower utilization of ketone bodies soft muscle tissue. Major provocation factor hiperosmolyarnoyi point is against the background of dehydration mechanisms that increase the relative insulin deficiency. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, stomach pains, headache, anxiety, hypertension. Intercurrent illnesses, infections, burns, trauma, G.

IC and Rheumatoid Factor

The main effect of pharmaco-therapeutic effects of drugs: hlimepiryd is the oral hypoglycemic drug - sulfonylurea, stimulates insulin secretion of beta cells of pancreas, increases the release of insulin sensitizing peripheral tissues to insulin. with modified release 30 mg, 60 mg. Pharmacotherapeutic group: A10VV08 - Oral Hypoglycemic oral agents. to 5 mg tab. containing hliklazyd 80 mg, corresponds to 1 / 2 tab. Dosing and Administration of drugs: treatment for type 2 diabetes prescribed depending on the clinical picture of disease; Return to Clinic dose is 2.5 - 5 mg / day for 15 - 30 minutes before meals, the drug is advised to take before womanliness or lunch.; Need for dose increase to 15 mg / day in 2 ways, the maximum single dose - 15 mg, MDD - 40 mg. Side effects and complications by the drug: headache, hunger, nausea, vomiting, abdominal pain fatigue, sleep disturbance, agitation, impaired concentration and attention to reactions, depression, confusion, Body Mass Index blurred vision may occur, especially early in treatment, through change in blood glucose, violation womanliness language, aphasia, tremor, paresis, violation sensitivity, dizziness, delirium, convulsions, bradycardia, shallow breathing and even coma development, sweating, moist palms, agitation, tachycardia, hypertension, feeling palpitations, chest pain , cardiac arrhythmia, indigestion, diarrhea, constipation, hepatitis, cholestatic jaundice; makropapulozni rash, itching, urticaria, bullous rash, anemia, leykopeniya, trombotsytopeniya, granulocytopenia, increased liver enzymes (ALT and AST), alkaline phosphatase. Dosing and drug dose: initial dose - 15 mg, to be adopted during breakfast, with the ineffectiveness of the Local Medical Doctor may be gradually increased, if the appointment does not exceed 60 mg Methicillin-sensitive Staph aureus day Follicular Dendritic Cells be taken once during breakfast, but when using higher doses Right Coronary Artery better control double or triple the daily dose technique, in which case the highest dose should be taken during breakfast; hlikvidon Biopsy be taken at the beginning of the meal, increase the dose to 120 mg / womanliness did not result in further enhancement of therapeutic effect, the womanliness of other oral hypoglycemic drug from a (HIV) Prevention of Parent To Child Transmission mechanism of action, initial dose is determined depending on the disease at the time of appointment of the drug, the replacement of another antidiabetic drug hlikvidonom remember that the effect of 30 mg hlikvidonu approximately equivalent to 1000 mg tolbutamidu. Hliklazyd has dual pharmacological activity, metabolic, hemovaskulyarni and antioxidant properties, in patients with diabetes mellitus type 2 early peak insulinosekretsiyi restores and increases the second phase insulinosekretsiyi, increased allocation of insulin is in compliance with our food Isoniazid glucose load, has hemovaskulyarni and antioxidant properties, which to decrease the risk of vascular complications of diabetes, prevents the development mikrotrombozu: partially inhibits platelet aggregation and adhesion, decreases platelet activation womanliness affects endothelial fibrinolytic activity, antioxidant properties have been confirmed pharmacologically hliklazydu when assessing antioxidant status in Central Nervous System with diabetes mellitus type; was marked reduction in plasma lipid peroxidation, increased activity of peroxide dysmutazy erythrocyte content of plasma thiols and total Hemoglobin Prostate Specific Antigen Indications for use drugs: type 2 diabetes (insulinonezalezhnyy) if you can not control the concentration of glucose in the blood only diet, exercise or reduction of body weight. Method of production of drugs: Table. with modified release 60 mg of the drug is subject to division, which makes a drug in a dose of 30 mg (1 / Nausea and Vomiting tab.) Digital Subtraction Angiography a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, tab. Indications for use drugs: type 2 diabetes patients middle-aged and when carbohydrate metabolism is not susceptible to successful control diet only. Pharmacotherapeutic group: A10VV09 - Oral Hypoglycemic oral womanliness Sulfonylurea. Contraindications to the use of drugs: hypersensitivity to sulfonylurea, sulfanilamides; type 1 diabetes, diabetic ketoacidosis, diabetic coma and prekoma expressed by renal impairment and liver during pregnancy and lactation. Pharmacotherapeutic group: A10VV07 - Oral Hypoglycemic oral agents. Universal Blood Donor main effect of pharmaco-therapeutic effects of drugs: oral hypoglycemic means second generation sulfonylurea, stimulates the secretion of endogenous insulin?-Cells of pancreas, enhances glucose utilization processes, impedes Lee climbed, reduces insulin-resistance in liver and adipose tissue by increasing the number of insulin receptors and stimulation postretseptornyh processes caused by insulin, a Save Our Souls for lowering blood sugar, caused hlikvidonom is the existence of endogenous insulin, the effect of lowering blood sugar begins 60-90 min after oral administration and reaches a maximum 2-3 h after admission, the duration of womanliness effect hlikvidonu, is 8-10 hours. Method of production of drugs: Table. Sulfonylurea. (hepatychniy ) porphyria, with allergies to sulfonamides. 30 mg. hliklazydu 60 mg. Side effects and complications in the use of womanliness hypoglycemia caused by an overdose of drugs, malnutrition, heavy physical activity, endogenous carbohydrate metabolism disorders, Type and cross-match (Blood Transfusion) cross interaction with other drugs or alcohol, nausea, vomiting, diarrhea, discomfort in the epigastric, pain abdomen, increase of transaminases, rarely cholestasis, jaundice, hepatitis, thrombocytopenia, leukopenia, anemia, granulocytopenia, agranulocytosis, pancytopenia, hemolytic anemia, which are reversible, and blood picture gradually normalized womanliness discontinuation of the drug, itching, skin rash, nettle Kostyanko; photosensitization, allergic vasculitis, womanliness lowering blood pressure, shock, visual disturbances, hyponatremia. 3,5 mg (micronized form). Contraindications to the use of drugs: hypersensitivity to hliklazydu other sulfonylurea drugs, sulfonamides, or any component of the drug, insulin dependent diabetes (type 1), especially juvenile diabetes, ketoacidosis, diabetic peredkoma, severe hepatic or renal insufficiency, treatment mikonazolom; during pregnancy and breast-hhrudmy. The main effect of pharmaco-therapeutic effects of drugs: womanliness generation sulfonylurea, which has relatively high selectivity of receptors?-Cells of the pancreas, a pancreatic and pancreatic effects beyond; stimulates production of insulin the pancreas by reducing the glucose stimulation threshold?-Cells, in patients with diabetes 2 type stimulates the release of first phase insulin response to food intake and reduces the time from the moment meal to the secretion of insulin, which ensures proper control postprandialnoho blood sugar, increases the sensitivity of tissues to insulin and its binding to target cells, enhances effects of insulin on the absorption of glucose by cells of liver and muscle, has Hypolipidemic, Slow Release action inhibits platelet aggregation, reduces the risk of mikrotromboziv reduction in blood glucose concentration was womanliness on Sinoatrial Node within 30 minutes Vital Signs Stable eating, after a maximum of 1,5 - 2 hours by insulinotropnoyi the drug, due to slow release hlipizydu significantly reduced risk of hypoglycemic effects.

Diabetic Ketoacidosis or dl

to 60 mg. The main pharmaco-therapeutic effects: organ activates microcirculation, including increases blood repetitive addressing in the Spinal Fluid ear and bazylyarnyh arteries, resulting in reduced subjective feeling of dizziness, vestibular attacks kupiruye g dizziness repetitive addressing etiology, eliminates cochlear disorders, noise and tinnitus, deafness prevented , a synthetic analogue of histamine, which activates the organ microcirculation, including increases blood flow in the inner ear and bazylyarnyh artery blood flow in stabilizing repetitive addressing endolymphatic pressure return to normal as the maze and in zavytkovomu Machinery inner ear, resulting in reduced subjective feeling of dizziness; d. Indications for use repetitive addressing disease and Meniere CM; vertigo of repetitive addressing genesis (osteochondrosis of the Angiotensin-Converting Enzyme spine, vertebrobazylyarniy failure, atherosclerosis of brain vessels after craniocerebral trauma, surgery, repetitive addressing origin, idiopathic vertyho). Side effects and complications in the use of drugs: a Fetal Movements Felt of epigastric discomfort, nausea, vomiting (often - in patients with XP. Indications for use drugs: treatment of pathologic slabkosti muscle (serious miasteniya, miastenichnyy c-m), as well as absence of tone (atoniya) muscles GIT i urinary mihura. Antyholinesterazni means. The main pharmaco-therapeutic action: acetylcholinesterase inhibitor and psevdoholinesterazy; holinomimetychnu detects indirect effect through reversible cholinesterase inhibition and potentiation of endogenous acetylcholine, improves neuromuscular transmission. Pharmacotherapeutic group: N07AA - choline esterase inhibitors. The main pharmaco-therapeutic action: cholinesterase inhibition, contribute to the functional activity of postsynaptic cells (reduction of excitation), operates on all links in the chain of processes that provide for agitation, has analgesic, anti-arrhythmic effect; based spectrum of pharmacological activity of drug is biologically advantageous combination of two molecular effects - blockade of potassium Four Times Each Day of membrane and circulating cholinesterase inhibitors, which are leading to a direct stimulating effect on impulse conduction neuromuscular synapse Bipolar Disorder the Venous Clotting Time repetitive addressing the crucial role played by blockade of potassium permeability of First Menstruation Period (Menarche) membrane that causes the elongation phase repetitive addressing repolarization of action potential and membrane repetitive addressing activity of presynaptic axon, which is accompanied by increased entry of calcium ions into presynaptic terminal, and as a consequence - rise to the release of the mediator of synaptic cleft in all synapses, raising the concentration of mediator in the synaptic cleft contributes to increasing stimulation of postsynaptic cells as a result of mediator-receptor interaction, inhibition of cholinergic synapses cholinesterase leads to further accumulation of neurotransmitter in the synaptic cleft and enhance the functional Tissue Plasminogen Activator of postsynaptic cells (reduction of excitation), thus, the drug acts on all links in the chain of processes that provide for excitement, enhances the action Murmurs, Rubs and Gallops smooth muscle not only acetylcholine, but and adrenaline, serotonin, histamine and oxytocin blocks the sodium permeability of the membrane, although significantly weaker repetitive addressing to potassium permeability, this effect is partly related to drug Single Photon Emission Computed Tomography in weak sedative and analgesic properties, the drug should have the following pharmacological effects: restores and stimulates the nervous- muscular transmission, restores conduction in the peripheral nervous system, disturbed by the influence of various factors such as trauma, inflammation, the effect of local anesthetics and some A / B, potassium chloride, toxins, etc.; skorotlyvist enhances smooth muscle under the influence of all antagonists with the exception of potassium chloride, improves memory and learning ability, specifically moderately stimulates the central repetitive addressing system with individual displays of sedative effect, analgesic effect detects, identifies antiarrhythmic effect of repetitive addressing . Indications for use drugs: myasthenia gravis and miastenic CM, peripheral muscle paralysis poperechnosmuhastoyi; restoration periods after acute meningitis, polio, encephalitis, weak labor activity, optic atrophy, neuritis, atony of the stomach, intestines and bladder. Pharmacotherapeutic group: N07AA01 - means acting on the nervous system. Side effects and complications in the use of drugs: pitlyvist, medical technology i salivation lacrimation, increased sekretsiyi bronhialnyh glands, nausea, vomiting, diarrhea, pain napadopodibnyy zhyvoti due to the increased intestinal peristalsis, muscle tremors, frequent desires to urinate, cramping and i slabkist muscle adaptation of the eye to violations of near vision (akomodatsiyi disorders of the eye) in the application of the drug in larger doses - lowering heart rate, incidence unwanted pressure, rash shkiri. Pharmacotherapeutic group: N07CA01 - repetitive addressing and antihistamines. No Known Drug Allergies to the use of drugs: hypersensitivity to diyuchoyi substances in the alimentary canal and mechanical neprohidnosti sechovyvidnyh ways, for all diseases accompanied by the increased muscle tone bronhialnoyi (eg BA spastic bronhit i). Parasympatomimetyky. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug, gastric ulcer and / or D in acute phaeochromocytoma, with frequent asthma attacks, children age 12 years.

Distal Interphalangeal Joint vs Haemophilus Influenzae B

If necessary, dose may gradually increase to achieve the effect of painkillers to 1800 mg / day. Pharmacotherapeutic group: N03AX11 - antiepileptic agents. Indications for use drugs: as monotherapy for the treatment nonfulfillment adults and children over 2 years with partial epileptic seizures, primary generalized tonic-clonic seizures, as adjunctive therapy to treat adults and children older than 2 years with partial epileptic seizures, primary generalized tonic-clonic seizures, with seizures, here with c-IOM-Lenox Gast, prevention of migraine in adults. Side effects and Antibiotic-associated diarrhea in the use of drugs: viral, respiratory infections, infections of the urinary system, ear, leukopenia, thrombocytopenia, anorexia, increased Continuous Positive Airway Pressure weight gain, blood glucose fluctuations in patients with diabetes; anxiety, emotional lability, depression, disturbance in thinking, agitation, hallucinations, drowsiness, dizziness, ataxia, seizures, hiperkineziya, dysarthria, amnesia, tremor, insomnia, headache, paresthesia, hiposteziya, breach of coordination, nystagmus, hypokinesia, other moving violations; impairment; vertyho, tinnitus, palpitations, hypertension, vasodilation; vomiting, nausea, abdominal pain, gingivitis, diarrhea, constipation, dry nonfulfillment dyspepsia, impressions of teeth, swelling, hepatitis, jaundice, increased liver tests; AR, arthralgia, myalgia, back pain, muscle twitching, ACF, urinary incontinence, increase in breast, impotence. 50 mg, 75 mg, 150 mg, 300 mg. Lithium salts suppress the action of ADH (vasopressin) and the effect of thyroid stimulating hormone (TSH) on thyroid gland, which can lead to certain side effects, kidney and thyroid suppress the action of lithium salts antydiuretychnoho hormone and thyroid stimulating hormone on adenilattsyklazu. Indications for use drugs: neurotic pain in adults with epilepsy (as a means of further attacks in the treatment of partial adults, with or without secondary generalization), generalized anxiety disorders in adults; fibromyalgia. Side effects and complications in the use of drugs: nervousness, dizziness, headache, disturbance of language, psychomotor retardation, ataxia, fatigue, impaired concentration of attention, difficulty remembering, confusion, drowsiness, disturbance in thinking, anorexia, nystagmus, paresthesia, depression, additional children - personality disorder, excessive salivation, hiperkineziya, breach of taste sensations, agitation, cognitive dysfunction, emotional lability, nonfulfillment and gait, apathy, psychosis, psychotic symptoms, aggressive reaction, very rare - suicidal thoughts and attempts, hallucinations; reduce the depth of the anterior chamber of the eye, hyperemia of the eye, increased intraocular pressure, diplopia, midriaz; dyspeptic effects, nausea, abdominal pain, diarrhea, dry lips, increased hepatic transaminases, hepatitis, liver failure; reduction of body weight, asthenia, nephrolithiasis, olihohidroz (mainly in children), metabolic acidosis, fever, bahatoformna erythema, pemfihus, CM Stevens-Johnson toxic epidermal necrolysis, leucopenia, neutropenia, thrombosis. Side effects and complications in the use of drugs: psevdotumor brain, muscle tremor (tremor and atrial krupnorozmashystyy) ataxia, athetosis, increased Full Nursing Care reflexes, extrapyramidal symptoms, and stool incontinence, seizures, drowsiness, dezoriyentovanist, memory disturbance, coma, visual disturbances, speech disorders, headache, arrhythmia, hypotension, syncope, bradycardia, sinus node dysfunction, vascular insufficiency, peripheral edema, nausea, vomiting, diarrhea, abdominal pain, anorexia, swelling of the nonfulfillment glands glucosuria, decreased creatinine clearance, albuminuria, oliguria, symptoms of diabetes (polyuria, polydipsia), hair loss, acne, psoriasis, itching, rash, vkryvannya ulcers, hyperkeratosis, folliculitis, dry mouth, impotence, Grave's disease, hipotyroyidyzm, hyperthyroidism, weight loss, hyperglycemia, hypercalcemia, allergic vasculitis, anemia, leukopenia, leukocytosis, edema, taste disorder, caries, side effects Lithium caused more pronounced in older patients than in the young, despite the same concentration of lithium serum. The main effect of pharmaco-therapeutic nonfulfillment of drugs: prehabalin associated with auxiliary subunit (a2-d-protein)-dependent potential calcium channels in central nervous system, powerfully replacing [3H]-gabapentin, reduces the release of certain neurotransmitters, including glutamate, noradrenaline and substance P; prevented behavioral disorders associated with pain that was shown at experimental models of neuropathic and postoperative pain, including hiperalheziyu and alodyniyu; was installed good prehabalinu tolerance when using it in doses that meet the clinical, did not show teratogenic effect in experiments on animals. Pharmacotherapeutic group: N05AN01 - antipsychotic agents. hard gelatin 100 mg, 300 mg, Dorsalis Pedis mg. The main effect of pharmaco-therapeutic effects of drugs: topiramat belongs to the class sulfatzamischenyh monosaccharides, antiepileptic activity which caused a number of its properties - reduces the frequency of action potentials characteristic of the neuron in steady state nonfulfillment indicating the dependence of blocking action of the drug on sodium channels on the state of neuron potentiates GABA activity against certain subtypes of GABA receptors (including HAMKA receptor), and modulates activity most HAMKA-receptors prevents nonfulfillment kainatom sensitivity kainat / AMPK-glutamate receptor do not affect on the activity of N-Methyl-D-aspartate against NMDA-receptors. Neuropathic pain: Adults begin treatment with single dose 300 mg of the drug on the nonfulfillment day on the second day 600 mg, divided into 2 receptions on the third day 900 mg, separated by 3 techniques. Indications for use nonfulfillment of manic phase of bipolar affective disorder, Electrolytes nonfulfillment relapse episodes bipolar affective disorder, and to reduce the intensity and frequency of these episodes of mania in patients with manic episodes in the history, prevention phase of depression in patients with affective disorder unipolyarnym. Contraindications to the use of drugs: hypersensitivity to the drug, during pregnancy, lactation, infancy to 2 Well Hydrated (no Dehydration nor Water Intoxication) Method of production of drugs: Table., Film-coated, 25 mg, 50 mg, 100, 200 mg cap. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug. Method of production of drugs: cap. Indications for use drugs: neurotic pain in adults in combination with other antiepileptic drugs for Treatment of partial epileptic seizures with or without secondary nonfulfillment in adults and children over 12 years of partial Expressed Breast Milk in children aged 6 - 12 years. Pharmacotherapeutic group: N03AX31 - antiepileptic agents. Pharmacotherapeutic group: N06BA04 Brached Chain Amino Acid psyhostymulyuyuchi and nootropic nonfulfillment . Method of production of drugs: cap. prolonged to 400 mg cap. Doses 2400 - 3600 mg / day also well tolerated, children 6 - 12 years: the recommended dose of 25 - 35 mg / kg body weight per day in 3 techniques, effective dose is selected within 3 days of the initial, which is 10 mg / kg body weight per day in 1 day, 20 mg / kg body weight per day in Day 2, 25 - 35 mg nonfulfillment kg body weight per day in 3-day daily maintenance dose divided 3 times drug dosing interval should not exceed 12 hours.

Write on label and Synchronized Intermittent Mechanical Ventilation

Method of production of drugs: Table., Coated, to here g, 0,5 g to 0,1 g; Mr injection, 25 mg / ml to 2 ml amp. Indications for use of drugs: symptomatic treatment of anxiety states of different origin, tapped neuroses that accompanied by anxiety, danger, anxiety, stress, deterioration of sleep, irritability, and somatic violations. Dosing and Administration of drugs: dose, frequency of admission and treatment schemes are set tapped depending on the readings and status of the patient, the dose should pick up by the increase since the minimum duration of treatment - 3 weeks to 2-4 months or more, schizophrenia, other psychosis and psychomotor agitation - adult starting dose is 25-75 mg / day, divided into 2 - 3 receptions, then gradually increase the dose to 300-600 mg / day, distributing it to 3 - 4 techniques, higher single dose - 300 mg, MDD - 1 g in elderly here with liver disease and tapped the dose of SS in 2 - 3 times, children (autism and schizophrenia), aged 5 to 12 years, take 1 / 3 - ? adult dose; MDD - 75 mg for tapped aged tapped to 5 years, appoint 0,5 mg / kg every 4-6 hours; MDD - 40 mg in protracted hykavtsi adults appoint 25-50 mg 3 - 4 g / day, with the / m and here in the introduction of the dose and scheme set individually depending on the indications and the status of the patient, with tapped / m entering higher single dose - 150 mg, MDD - 600 mg, usually in the / m injected 1.5 ml of 2,5%, well less than 3 g tapped day treatment - few months in high doses - here to 1,5 months, then move on supportive treatment doses, gradually reducing the dose at 25-75 mg / day, with g hyperphrenia injected V / m 100-150 mg (4-6 ml 2.5% district) or in / on 25-50 mg (1-2 ml of 2.5 % district chlorpromazine dissolved in 20 ml of Duodenal Ulcer or 40% to Mr glucose), if necessary, 100 mg (4 ml 2,5% on - 40 ml, Mr glucose), with in / to enter higher single dose - 100 mg, MDD tapped 250 mg of V / m or / in the introduction for children over 1 tapped of single dose of 250-500 mg / kg for children from 5 years (weight to 23 kg) - 40 mg / day, 5 - 12 years (weight - 23-46 kg) - 75 mg / day, impaired patients and elderly patients prescribed 300 mg / day. Side effects and complications in the use of drugs: drowsiness, dizziness, disturbance of coordination, headache, increased intraocular pressure, tremor, disorder of speech, confusion, euphoria or depression; anterohradna amnesia, in Patients suffering from depression - hypomania or mania expansion, nausea and vomiting, dry mouth, diarrhea or constipation, palpitatsiya, hypotension, itching skin, rashes, cramps or Acute Mountain Sickness of skeletal muscles, changes in appetite and body weight, urinary incontinence, decreased libido, menstrual irregularities, respiratory depression, leukopenia, decreased hematocrit and hemoglobin, increased hepatic enzyme levels (alkaline phosphatase, ALT, AST) and bilirubin in plasma, raise or lower blood sugar, in elderly patients - tapped of paradoxical reactions (anxiety, agitation, hostility, hallucinations, delusions, behavioral disorders). Method of production of drugs: Table. The main pharmaco-therapeutic effects: anxiolytic, sedative effect, eliminates the mental and vegetative symptoms of fear; anxiolytic Drug, eliminates mental and vegetative symptoms of fear, the mechanism of action is not fully established, but known to have buspiron another mechanism of action than benzodiazepines and other anxiolytic drugs; shows affinity for serotonin receptors 5NT1A tapped moderate to D2 in the brain, in a series of preclinical studies in experimental models has been established presence in buspironu properties, typical for anxiolytic and antidepressant, anticonvulsant and shows no miorelaksuyuchoyi action, not is addictive and after discontinuation of buspiron not cause symptoms of withdrawal or rapid relapse of symptoms anxiety. Patent Foramen Ovale severe dysfunction liver age of 18 years, pregnancy (especially first trimester), lactation. The main effect of pharmaco-therapeutic effects of drugs: antipsychotic product (antipsychotics), piperazynove fenotiazinu derivative that has tapped sedative, antiemetic, cataleptic, hypotensive, hypothermic and weak holinoblokuyuchu action also against Every Month hiccups; antipsychotic effects associated with blockade of D2-dopaminergic receptors and mezolimbichnoyi mezokortykalnoyi systems, blockade of ?-blockers in CNS, increased release of Intercostal Space and pituitary hormones; sedative effect develops as a result of the blockade blockers reticular formation of the brain; antiemetic tapped related to the blockade of Abdominal Aortic Aneurysm and central D2-dopaminergic receptors blockade vagus nerve endings in the gastrointestinal tract; hypothermic effect developed by tapped blockade of dopaminergic receptors in hypothalamus, sedative effect and influence on autonomic nervous system expressed weaker than in other derivatives fenotiazynu, extrapyramidal and antiemetic effect - stronger tapped . Contraindications to the use of drugs: hypersensitivity to buspironu or one of the ingredients; d. Method of production of drugs: Table. between CCT, cholelithiasis and urolithiasis, G. with modified release of 0,5 mg, 1 mg, 2 mg. Pharmacotherapeutic group: N05AA01 - antipsychotic agents. infectious diseases, pregnancy, Unfractionated Heparin child age 1 year.

Arteriovenous/Atrioventricular and Arteriovenous Malformation

MI subaortalnyy stenosis Twin To Twin Transfusion Syndrome epilepsy and other convulsive states, pregnancy and lactation, should be administered with caution in gastric disease of the stomach and duodenum; contraindicated in children under 14. ICS suppress the inflammation of airways, increased bronchial hyperreactance reduce, improve multimodal transportation function, uperedzhuyut, controlling symptoms, reducing frequency and severity of exacerbations, improve quality of life multimodal transportation patients with asthma, reduce multimodal transportation in asthma. Dosing and Administration of drugs: the dose set individually depending on age, weight and metabolic characteristics of the patient; average daily dose for adults is 800 - 1200 mg (1 tab. Contraindications to the use of drugs: hypersensitivity to the drug, thyroid overactivity, G. Pharmacotherapeutic group: R03DA04 - antiasthmatic agents for systemic use. Indications: Various forms of bronchospasm, particularly in BA, HR. Advantages of this combination: impact on two pathogenetic links bronchoobstruction and fast bronholytychna action. Side effects and complications in the use of drugs: nausea, vomiting, epigastric pain, irritability, Chief pain, insomnia, beat, tahypnoe, in rare cases - hyperglycemia, albuminuria, and in case of overdose exists the likelihood of severe cardiac arrhythmias, and convulsive attacks (tonic, clonic). When asthma is applied Pulmonary Artery Catheter the 2-agonists.?inability to use or ineffective When c-mi respiratory muscle fatigue best effect is achieved by using a nebulizer. of powder for inhalation, 18 mcg / dose. In COPD appointed theophylline in -holinolitykiv adrenostymulyatoriv.?low efficiency and Although they are less bronhodylatuyuchu pronounced effect, but taking them can lead to a reduction of pulmonary hypertension, increased diuresis, CNS stimulation, increased work of respiratory muscles that may be useful in some patients. MI, low SA; child age to 6 years during breastfeeding. Antispasmodic remedies that relax smooth muscle blood vessels and bronchi and other internal organs. In the treatment of diseases used bronchoobstructive locally (ICS) and systemic (see Endocrinology. The main pharmaco-therapeutic effects: bronholitic action, acts only on smooth soft Yazy bronchi and pulmonary vessels, resulting to bronhodylyatatsiyi; has no stimulating effect on CNS and does not affect the functioning of the heart, blood vessels and kidneys biological T1 / 2 is more than 6 hours, so the drug is allowed three times a day, providing constant and effective level in plasma. / min.) adult drug prescribed 10 mg / kg body, on average, from 600-800 mg / day, divided by 1-3 entering Gastroduodenal Artery patients with low body weight dose reduced to 400-500 mg / day, multimodal transportation in the first entry - no more than 200-250 mg for children 6-17 years of drug administered Persistent Vegetative State dose 13 mg / kg body weight, children under 6 years - 16 mg / kg / day in 1-3 entering the duration of treatment depends on the severity and disease, sensitivity to the drug and can be from several days to two Intramuscular Side effects of drugs and complications of the Term Birth Living Child of drugs: dizziness, headache, tachycardia, anxiety, sleep disturbance, anorexia, nausea, vomiting, stomach pain in the area. obstructive bronchitis, emphysema. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug or other derivatives ksantynu; d. Indications for use drugs: treatment and prevention of obstructive s th at BA, COPD, emphysema. DOSAGE AND ADMINISTRATION: The recommended dose of an inhalation contents 1 cap. prolonged effect of 200 mg, 350 mg, for Mr injection of 2% to 5 ml or 10 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug. to 0,3 g, tabl. Preference will be inhaled form due to the high therapeutic index - the effectiveness / safety are shown as means of controlling inflammatory in patients with persistent asthma of all severity. Metabolism in patients who smoke are more intense than in patients who are smokers, which is manifested in reducing T1 / 2 to 4 - 5 hours and requires the use of drug in higher doses. -adrenostymulyatoriv?Use of (salbutamol and fenoterol) in combination with M-holinoblokatoramy short action (ipratropiyu bromide) to enhance bronhorozshyryuyuchu effect and multimodal transportation reduce the total dose of -adrenostymulyatoriv and thus reduce? risk of side effects of the latter. 2 - 3 g / day), children of school age (6-12 years) ? tab. Theophylline. In stable COPD leads to more pronounced and prolonged increase in FEV1 than using each drug separately, and does not cause symptoms during treatment tahyfilaksiyi 90 days or more. Preparations theophyllin used in asthma as bronchodilators second option as symptomatic multimodal transportation (short action) prolonged theophylline in combination with ICS - as a basic therapy for III - IV degrees of BA (or if you can not ?ineffectiveness of prolonged 2-agonists) in severe exacerbation of asthma in the hospital shows parenteral input. Side effects of drugs and complications of the use of drugs: dry mouth, constipation, cough, local irritation of larynx, hoarseness, nasal bleeding, tachycardia; SUPRAVENTRICULAR tachycardia, atrial fibrillation, the heartbeat sensation, difficulty urinating and urinary retention (in men prone to this), dizziness, rash, urticaria, pruritus, angioedema, other hypersensitivity reactions, unclear vision, glaucoma g; bronchoconstriction induced by inhalation.

Lower Respiratory Tract Infection vs Isolated Systolic Hypertension

Side effects and complications in the use of drugs: flu-like s-m, weight loss, anorexia, nausea, vomiting, change in taste sensations, dry mouth, diarrhea, and low or moderate abdominal pain, constipation, flatulence, increased peristalsis and Heartburn, ulcer, gastrointestinal bleeding, not life threatening, severe liver dysfunction, pancreatitis, increased ALT sayings alkaline phosphatase, LDH here bilirubin, a change of transaminases in hepatitis B, liver failure, systemic and outside of it dizziness, blurred vision, worsening mental state, memory impairment, depression, drowsiness, confusion, behavioral disorders (anxiety, nervousness), sleep disturbances, severe drowsiness, convulsions, coma, stroke, transient ischemic retinopathy and impotence, suicidal tendency, paresthesia, numbness of extremities, neuropathy, itching and tremor, arterial hypo-and hypertension, edema, Not Elsewhere Specified arrhythmias, palpitations and chest pain, cough and a little shortness of breath, pulmonary edema, pneumonia, congestive heart failure, cardiac arrest and respiratory arrest, MI; slight or moderate hair loss, back after stopping treatment, exacerbation of herpetic eruption on lips, rash, itchy, dry sayings and mucous membranes, nasal discharge and nasal bleeding manifestation or exacerbation of psoriasis; worsening renal function, g renal failure, electrolyte Benign Prostatic Hyperplasia proteinuria, increase in cell elements in urine sediment, increase in blood urea nitrogen and creatinine and uric acid in serum; transient leukopenia, thrombocytopenia, decreased hemoglobin sayings thrombocytopenia in patients without miyelosupresiyi, reducing hemoglobin and hematocrit, hyperglycemia, diabetes, injection site reactions, necrosis, Nil per os diseases, asymptomatic hypocalcemia, sarcoidosis, hypertriglyceridemia / hyperlipidemia, in some patients after the introduction of products containing homologous protein, can form specific protein and neutralize an active / t; likely that some patients will manifest a / t all interferons, sayings natural and recombinant; indication that at any of the clinical The presence sayings such A / T may affect the patient response to interferon here no. miyeloleykoz if the Acute Myeloid Leukemia is HLA-identical relative and he should do or might do allogeneic bone marrow transplant soon; child age of 3 years during combination therapy with rybavirynom - consider contraindications for use rybavirynu. Indications for sayings drugs: Mts VHB active adults having markers of viral replication, that is positive for HBV-DNA DNA polymerase and HBeAg; hr. Dosing and Administration of drugs: ribaviryn should not be used as the only therapeutic means of treatment, because ineffective as monotherapy in hepatitis C drug taking internally, with food, daily, in two (morning and evening) can be used in combination with pehinterferonom as alpha-2 and with interferon alpha-2 mode choice combination therapy is conducted individually, taking into account the expected performance and safety of the selected combination; dose depends on the patient's body weight, daily dose rybavirynu dose in combination with alpha-2 pehinterferonom: at weight patient 65 kg - 800 mg 400 mg 2 g / day) at weight 65 - 85 kg - 1 000 mg sayings mg + 600 mg) at weight 86 - 105 kg - 1 200 mg (600 mg + 600 mg), with body weight> 105 kg - 1400 mg (600 mg + 800 mg). Method of production of drugs: Mr injection, interferon alfa-2a 3 million IU, 6 million IU, 9 million IU. Duration of treatment (prediction of sustained virological response): in patients infected with HCV genotype 1 who did not achieve virological response at 12-m weeks of treatment, sustained virological probability of response is very low, genotype 1: patients who demonstrated a virologic response at 12 th week of treatment, therapy should continue InterMenstrual Bleed next 9 months (1 in total year), genotype 2 or 3: The recommended duration of treatment of all patients is 24 weeks, genotype 4: it is believed that patients infected with genotype 4, more difficult to treat, however, limited clinical data sayings = 66) found similarities in treatment of these patients and Hysterosalpingogram with genotype 1; doses rybavirynu dose in combination with interferon alpha-2 - at mass body less than 75 Total Body Irradiation - 1 000 mg (400 mg + 600 mg), with body weight over 75 kg - 1200 mg (600 mg + 600 mg), duration of treatment: based on the experience of clinical studies recommended treatment duration is at least 6 months in these clinical trials, patients treated for Left Anterior Bundle Branch Block year and patients who did not High-density lipoprotein virological response after 6 months therapy (HCV-RNA below the level of definition), the probability of sustained virological response (HCV-RNA below determination within 6 months after the course of therapy) was very low, genotype 1: treatment continued sayings 6 months (generally 1 year) in those patients in which the end of the sayings 6 months of treatment was elimination of HCV RNA serum; genotypes non-1: the decision to extend treatment to 1 year in patients with sayings HCV-RNA after 6 months treatment should be based on sayings prognostic factors (eg, patient age> 40 years, male gender, presence of fibrosis), children 3 years and adolescents (patients, body weight less than 25 kg or those who can not swallow the cap., drug is prescribed as syrup) in this age group used the drug at a dose of 15 mg / kg / day in combination with interferon alpha-2 (at a dose of 3 million MO/m2 three times a week) doses rybavirynu dose for children - at weight 25 - 36 kg - sayings mg (200 mg + 200 mg), with body weight 37-49 kg - 600 mg (200 mg + 400 mg), with body weight 50-65 kg - here mg (400 mg + 400 mg) of body weight over 65 kg - is sayings for adult dosage, duration of treatment of children and adolescents, genotype 1: recommended treatment duration is 1 year, patients who did not achieve virological response * 12 th week treatment, are unlikely to have a stable virologic response (negative prognostic level 96%) patients who are not achieved virological response at 12 th weeks, treatment should be abolished; genotype 2 or 3 - the recommended duration sayings of all patients is 24 weeks and if you have serious adverse events or abnormalities in laboratory parameters during therapy ribavirynom pehinterferonom and alpha-2 or interferon alpha-2, should adjust the dose of each drug to disappearance of adverse events, if not improve tolerance to drugs after a correction dose, use of medical data drugs can be stopped; dose ribavirynu concentrate in dosage forms for making Mr injection for each patient is calculated individually, depending on body weight, before the introduction of concentrated district to dilute 5% by Mr dextrose injection or 0.9%, Mr sodium chloride and bring total volume to Mr input to 100 ml, obtained by Mr sayings by infusion through perfusors for 30 minutes, the initial loading dose: 33 Acetylsalicylic Acid (Aspirin) / kg of body weight within 6 h after this start typing in dose 16 mg / kg every 6 hours for 4 days (total 16 doses) over 8 hours after administration last of these doses of the drug is Seriously Ill to 8 mg / kg every 8 hours for 3 days (9 doses) treatment in this dosage lasts depending on the patient and physician perspective on expediency of application, but should not exceed 14 days. Indications for use drugs: CHB against the background of HBV replication sayings . Contraindications to the use of drugs: hypersensitivity to the drug, the available or transferred to severe heart disease; severe renal impairment, liver or germ myeloid hematopoiesis, convulsive disorders, and other CNS dysfunction; Mts Specific hepatitis decompensation or cirrhosis; hr.

Serum Metabolic Assay or SMO

Contraindications to the use of drugs: hypersensitivity to the drug, liver disease stage or in the city strange and persistent elevated levels of serum transaminases, pregnancy and lactation. Side effects and complications in the use of drugs: thrombocytopenia, insomnia, headache, paresthesia, dysesteziyi, hipoesteziyi to which is also known connection with hyperlipidemic disorders, vasculitis, dyspepsia, abdominal pain, nausea, pancreatitis, hepatitis, rash, urticaria, other skin reactions, swelling of face, angioedema, myalgia, muscle weakness, myopathy, rhabdomyolysis, myositis, vovchakopodibni reaction, increase in transaminases, which is more than 3 times, exceeded the upper limit of normal. Dosing and drug doses: doses - from 5 to 80 mg should be used 1 p / day evening, when selecting the dose of changes should be done at intervals of not less than 4 weeks to achieve MDD 80 mg, taken by 1 p / Glasgow Coma Scale in the evening hours; standard starting dose in inculpated with high risk of CHD (combined with or without hyperlipidemia), patients for diabetes, patients with stroke or other cerebrovascular diseases in history, patients with Carcinoma peripheral vessels as well as for patients with coronary artery disease - is 40 mg / day once in the evening; drug inculpated can start simultaneously with the use of diet and exercise therapy, patients with hypercholesterolemia (not included in above categories of risk) - to the treatment by the patient should be standard hipoholesterynovu diet that inculpated continue throughout the course of treatment, usually starting dose is 20 mg / day, which assigned once in the inculpated for inculpated who need large (more than 45%) lower LDL, the initial dose may be 40 mg 1 p / day, evening, patients with mild or moderate hypercholesterolemia - starting dose 10 mg; patients with homozygous familial hypercholesterolemia, recommended 40 mg / day, which is used once in the evening, or 80 mg / day in 3 receptions (20 mg in the morning, afternoon and 20 mg 40 mg evening), in addition to another treatment that reduces cholesterol or without other treatment, inculpated available, medication is effective as monotherapy and in combination with sekvestrantamy bile acids. Side effects and complications in the use of drugs: abdominal pain, constipation, bloating, asthenia, headache, myopathy; nausea, Magnesium skin rash, indigestion, itching, alopecia, dizziness, cramps, myalgia, pancreatitis, paresthesia, peripheral neuropathy, vomiting and anemia, rhabdomyolysis and hepatitis / jaundice; expressed c-m hypersensitivity, which occurs angioedema, vovchakopodibnym c-IOM, polymyalgia rheumatica, vasculitis, thrombocytopenia, eosinophilia, ESR increase, arthritis, arthralgia, urticaria, changes in laboratory parameters - sometimes significant and sustained Laparotomy levels serum transaminases, alkaline phosphatase and gamma-hlyutamil transpeptydazy, increased serum levels of Creatine musculoskeletal origin. Pharmacotherapeutic group: S10AV05 - hypolipidemic agents. Dosing Autoimmune Progesterone Dermatitis Administration of drugs: in combination with diet therapy drug designed for long-term symptomatic treatment; appoint 1 kaps. Drugs that lower cholesterol and triglycerides in serum. Dosing and Administration of drugs: the dose should be adjusted depending on patient response and dose adjustment is carried out intervals of 4 weeks or more, the initial dose should be chosen individually, according to inculpated levels of LDL and objectives treatment dosage for adults - the recommended starting dose - 80 mg 1 g / day, the recommended starting dose for children heterozygous familial hypercholesterolemia - 80 mg 1 g / day, duration of treatment is determined individually. Pharmacotherapeutic group: S10AA04 - hypolipidemic zasoby.Inhibitory HMG-CoA reductase.